Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/308998
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders |
Autor: | Valor, Luis Miguel CSIC ORCID; Viosca, José CSIC; López-Atalaya, José P. CSIC ORCID; Barco, Ángel CSIC ORCID | Fecha de publicación: | 2013 | Editor: | Bentham Science Publishers | Citación: | Current Pharmaceutical Design 19: 5051-5064 (2013) | Resumen: | Neuropsychiatric pathologies, including neurodegenerative diseases and neurodevelopmental syndromes, are frequently associated with dysregulation of various essential cellular mechanisms, such as transcription, mitochondrial respiration and protein degradation. In these complex scenarios, it is difficult to pinpoint the specific molecular dysfunction that initiated the pathology or that led to the fatal cascade of events that ends with the death of the neuron. Among the possible original factors, epigenetic dysregulation has attracted special attention. This review focuses on two highly related epigenetic factors that are directly involved in a number of neurological disorders, the lysine acetyltransferases CREB-binding protein (CBP) and E1A-associated protein p300 (p300). We first comment on the role of chromatin acetylation and the enzymes that control it, particularly CBP and p300, in neuronal plasticity and cognition. Next, we describe the involvement of these proteins in intellectual disability and in different neurodegenerative diseases. Finally, we discuss the potential of ameliorative strategies targeting CBP/p300 for the treatment of these disorders. | Versión del editor: | https://doi.org/10.2174/13816128113199990382 | URI: | http://hdl.handle.net/10261/308998 | DOI: | 10.2174/13816128113199990382 | E-ISSN: | 1381-6128 |
Aparece en las colecciones: | (IN) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
lysinedisorder.pdf | 721,2 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
74
checked on 18-abr-2024
SCOPUSTM
Citations
118
checked on 28-abr-2024
WEB OF SCIENCETM
Citations
110
checked on 28-feb-2024
Page view(s)
59
checked on 30-abr-2024
Download(s)
14
checked on 30-abr-2024